fda bpc-157 not approved panel votes to place popular peptide on compounding list A step towards expanded patient

A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link fda bpc 157 not approved for human use warning Peptides like BPC 157 and TB 500 FDA advisers back first four of seven unapproved peptides under review for looser rules Reuters

SKU: 45405041286 · From iglepidom.org